Danaher Yönetim

Yönetim kriter kontrolleri 3/4

Danaher CEO'su Rainer Blair, Sep2020 tarihinde atandı, in görev süresi 4.17 yıldır. in toplam yıllık tazminatı $ 20.90M olup, şirket hissesi ve opsiyonları dahil olmak üzere 6.2% maaş ve 93.8% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.014% ine doğrudan sahiptir ve bu hisseler $ 24.51M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 5.8 yıl ve 14.5 yıldır.

Anahtar bilgiler

Rainer Blair

İcra Kurulu Başkanı

US$20.9m

Toplam tazminat

CEO maaş yüzdesi	6.2%
CEO görev süresi	4.2yrs
CEO sahipliği	0.01%
Yönetim ortalama görev süresi	5.8yrs
Yönetim Kurulu ortalama görev süresi	14.5yrs

Son yönetim güncellemeleri

Recent updates

Mar Vista - Danaher: Headwinds Are Primarily Cyclical, Growth To Regain Momentum

Jun 20

Is Danaher Corporation (NYSE:DHR) Worth US$263 Based On Its Intrinsic Value?

Jun 05

Is Danaher (NYSE:DHR) A Risky Investment?

May 21

It's Unlikely That Danaher Corporation's (NYSE:DHR) CEO Will See A Huge Pay Rise This Year

May 01

Value Vs. Growth? Danaher Says Why Not Both?

Apr 25

Danaher: All In On Life Sciences, And Market Update

Mar 27

Is Now An Opportune Moment To Examine Danaher Corporation (NYSE:DHR)?

Mar 11

Danaher Corporation's (NYSE:DHR) Price Is Out Of Tune With Earnings

Feb 10

Bull Case Confirmed: Danaher Is Still One Of The Best Stocks To Buy Long-Term

Jan 30

Is Danaher (NYSE:DHR) Using Too Much Debt?

Jan 12

My Top 2024 Stock Pick: Danaher

Dec 27

Danaher: Poised For Long-Term Growth Despite Near-Term Hurdles

Nov 26

RGA Investment Advisors - Danaher: Purity In The Crown Jewel Of Bioprocessing

Nov 19

Why Danaher Is One Of My Favorite Long-Term Investments

Oct 26

Danaher: Short-Term Headwinds, But Long-Term Tailwinds

Oct 17

Should Danaher Investors Sell New Veralto Shares?

Oct 02

Danaher Corporation's (NYSE:DHR) Intrinsic Value Is Potentially 18% Below Its Share Price

Sep 30

Danaher: A Lost Year

Aug 30

Third Point - Danaher: Don't Be Surprised If Growth Rate Moves To Low Teens

Aug 02

Danaher: A Compounding Icon At A Fair Price

Jul 25

These 4 Measures Indicate That Danaher (NYSE:DHR) Is Using Debt Reasonably Well

Jul 13

Calculating The Intrinsic Value Of Danaher Corporation (NYSE:DHR)

Jun 28

Danaher: Seizing The Buying Opportunity In A Temporary Bioprocessing Slump

Jun 22

At US$238, Is It Time To Put Danaher Corporation (NYSE:DHR) On Your Watch List?

Jun 15

Danaher: A Great Chance To Buy This Long-Term Compounder

May 23

With EPS Growth And More, Danaher (NYSE:DHR) Makes An Interesting Case

Apr 26

CEO Tazminat Analizi

Rainer Blair'un ücretlendirmesi Danaher'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Sep 27 2024	n/a	n/a	US$4b
Jun 28 2024	n/a	n/a	US$4b
Mar 29 2024	n/a	n/a	US$4b
Dec 31 2023	US$21m	US$1m	US$4b
Sep 29 2023	n/a	n/a	US$4b
Jun 30 2023	n/a	n/a	US$5b
Mar 31 2023	n/a	n/a	US$6b
Dec 31 2022	US$20m	US$1m	US$6b
Sep 30 2022	n/a	n/a	US$7b
Jul 01 2022	n/a	n/a	US$6b
Apr 01 2022	n/a	n/a	US$6b
Dec 31 2021	US$17m	US$1m	US$5b
Oct 01 2021	n/a	n/a	US$6b
Jul 02 2021	n/a	n/a	US$5b
Apr 02 2021	n/a	n/a	US$5b
Dec 31 2020	US$10m	US$949k	US$4b
Oct 02 2020	n/a	n/a	US$3b
Jul 03 2020	n/a	n/a	US$3b
Apr 03 2020	n/a	n/a	US$3b
Dec 31 2019	US$7m	US$840k	US$2b
Sep 27 2019	n/a	n/a	US$2b
Jun 28 2019	n/a	n/a	US$2b
Mar 29 2019	n/a	n/a	US$2b
Dec 31 2018	US$5m	US$700k	US$2b
Sep 28 2018	n/a	n/a	US$3b
Jun 29 2018	n/a	n/a	US$3b
Mar 30 2018	n/a	n/a	US$3b
Dec 31 2017	US$4m	US$625k	US$2b

Tazminat ve Piyasa: Rainer 'nin toplam tazminatı ($USD 20.90M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 12.86M ).

Tazminat ve Kazançlar: Rainer 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.

CEO

Rainer Blair (60 yo)

4.2yrs

Görev süresi

US$20,903,282

Tazminat

Mr. Rainer M. Blair serves as Director at Nestlé S.A. since April 20, 2023. He serves as President, Chief Executive Officer and Director at Danaher Corporation since September 1, 2020. Mr. Blair served as...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Steven Rales	Co-Founder & Chairman	41.8yrs	Veri yok	6.02% $ 10.9b
Rainer Blair	President	4.2yrs	US$20.90m	0.014% $ 24.5m
Mitchell Rales	Co-Founder & Director	41.8yrs	Veri yok	4.86% $ 8.8b
Matthew McGrew	CFO & Executive VP	5.8yrs	US$7.50m	0.0053% $ 9.6m
Jose-Carlos Gutierrez-Ramos	Senior VP & Chief Science Officer	3.9yrs	US$7.20m	0.00037% $ 668.3k
Georgeann Couchara	Senior Vice President of Human Resources	2.6yrs	US$5.25m	0.00015% $ 270.9k
Christopher Bouda	VP & Chief Accounting Officer	2.8yrs	Veri yok	0.00081% $ 1.5m
John Bedford	Vice President of Investor Relations	no data	Veri yok	Veri yok
Brian Ellis	Senior VP	8.8yrs	US$3.56m	0.0028% $ 5.1m
Daniel Raskas	Senior Vice President of Corporate Development	14.8yrs	Veri yok	0.0033% $ 5.9m
William King	Senior Vice President of Strategic Development	10.5yrs	Veri yok	0.0067% $ 12.0m
Christopher Riley	Executive VP of Biotechnology Group & CEO of Cytiva	less than a year	Veri yok	0.0020% $ 3.6m

5.8yrs

Ortalama Görev Süresi

57yo

Ortalama Yaş

Deneyimli Yönetim: DHR 'un yönetim ekibi deneyimli ve deneyimlidir ( 5.8 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Steven Rales	Co-Founder & Chairman	41.8yrs	Veri yok	6.02% $ 10.9b
Rainer Blair	President	4.2yrs	US$20.90m	0.014% $ 24.5m
Mitchell Rales	Co-Founder & Director	41.8yrs	Veri yok	4.86% $ 8.8b
Alan Spoon	Independent Director	25.8yrs	US$338.13k	0.011% $ 20.4m
John Schwieters	Independent Director	21.3yrs	US$351.13k	0.0054% $ 9.8m
Elias Zerhouni	Independent Director	15.8yrs	US$338.13k	0.0024% $ 4.3m
Raymond Stevens	Independent Director	7.8yrs	US$318.13k	0% $ 0
Angela Caliendo	Member of Scientific Advisory Board	3.6yrs	Veri yok	Veri yok
Linda Filler	Lead Independent Director	18.9yrs	US$382.13k	0.0057% $ 10.3m
Teri List-Stoll	Independent Director	13.2yrs	US$318.13k	0% $ 0
Jessica Mega	Independent Director	5yrs	US$318.13k	0% $ 0
Pardis Sabeti	Director	5yrs	US$318.13k	0% $ 0

14.5yrs

Ortalama Görev Süresi

64yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: DHR 'in yönetim kurulu deneyimli ve tecrübelidir (ortalama görev süresi 14.5 yıldır).

Danaher Yönetim

Yönetim kriter kontrolleri 3/4

Anahtar bilgiler

Son yönetim güncellemeleri

CFO & Executive VP notifies of intention to sell stock

Insider recently sold US$3.9m worth of stock

Danaher Corporation Announces Executive Changes

Danaher Corporation Appoints Martin Stumpe as Chief Data & Artificial Intelligence Officer

President notifies of intention to sell stock

CFO & Executive VP recently sold US$5.4m worth of stock

Recent updates

Understanding Danaher's Cautiousness

Third quarter 2024 earnings: EPS in line with analyst expectations despite revenue beat

Is There Now An Opportunity In Danaher Corporation (NYSE:DHR)?

Danaher Q3 Preview: Market Share Gains In Molecular Testing

Dividend of US$0.27 announced

Is Danaher Corporation (NYSE:DHR) Trading At A 32% Discount?

Here's Why Danaher (NYSE:DHR) Can Manage Its Debt Responsibly

Danaher: Lofty Price, Bright Future

Danaher Corporation (NYSE:DHR) acquired Genedata AG.

Danaher Corporation's (NYSE:DHR) Price In Tune With Earnings

CFO & Executive VP notifies of intention to sell stock

Insider recently sold US$3.9m worth of stock

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Danaher: Valuation Now Too High Even Compared To Own High Standards

What Is Danaher Corporation's (NYSE:DHR) Share Price Doing?

Mar Vista - Danaher: Headwinds Are Primarily Cyclical, Growth To Regain Momentum

Danaher Corporation Announces Executive Changes

Danaher Corporation Appoints Martin Stumpe as Chief Data & Artificial Intelligence Officer

Is Danaher Corporation (NYSE:DHR) Worth US$263 Based On Its Intrinsic Value?

Now 20% overvalued after recent price rise

Is Danaher (NYSE:DHR) A Risky Investment?

President notifies of intention to sell stock

Now 21% overvalued after recent price rise

CFO & Executive VP recently sold US$5.4m worth of stock

Dividend of US$0.27 announced

Danaher Announces Quarterly Dividend, Payable on July 26, 2024

It's Unlikely That Danaher Corporation's (NYSE:DHR) CEO Will See A Huge Pay Rise This Year

Senior VP recently sold US$1.0m worth of stock

Value Vs. Growth? Danaher Says Why Not Both?

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Danaher: All In On Life Sciences, And Market Update

Danaher Corporation to Report Q1, 2024 Results on Apr 23, 2024

Upcoming dividend of US$0.27 per share

Is Now An Opportune Moment To Examine Danaher Corporation (NYSE:DHR)?

Insider notifies of intention to sell stock

Dividend of US$0.27 announced

Danaher Corporation Approves Regular Quarterly Cash Dividend, Payable on April 26, 2024

Danaher Corporation, Annual General Meeting, May 07, 2024

Danaher Corporation's (NYSE:DHR) Price Is Out Of Tune With Earnings

Consensus EPS estimates fall by 11%

Full year 2023 earnings: EPS and revenues miss analyst expectations

Bull Case Confirmed: Danaher Is Still One Of The Best Stocks To Buy Long-Term

Now 20% overvalued after recent price rise

Is Danaher (NYSE:DHR) Using Too Much Debt?

Danaher Corporation Provides Earnings Guidance for the Fourth Quarter 2023

My Top 2024 Stock Pick: Danaher

Danaher Corporation to Report Q4, 2023 Results on Jan 30, 2024

Upcoming dividend of US$0.24 per share at 0.5% yield

Danaher Corporation (NYSE:DHR) completed the acquisition of Abcam plc (NasdaqGS:ABCM).

Danaher Corporation Announces Quarterly Dividend, Payable on January 26, 2024

Danaher: Poised For Long-Term Growth Despite Near-Term Hurdles

RGA Investment Advisors - Danaher: Purity In The Crown Jewel Of Bioprocessing

Why Danaher Is One Of My Favorite Long-Term Investments

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Consensus EPS estimates fall by 10%

Danaher: Short-Term Headwinds, But Long-Term Tailwinds

Now 20% undervalued after recent price drop

Upcoming dividend of US$0.27 per share at 0.5% yield

Danaher Corporation completed the Spin-Off of Veralto Corporation (NYSE:VLTO.WI).

Should Danaher Investors Sell New Veralto Shares?

Danaher Corporation's (NYSE:DHR) Intrinsic Value Is Potentially 18% Below Its Share Price

Danaher Corporation to Report Q3, 2023 Results on Oct 24, 2023

Danaher to Provide Cepheid's Tuberculosis Test to the Global Fund At Cost

Danaher Corporation Announces Quarterly Cash Dividend, Payable on October 27, 2023

Danaher: A Lost Year

Danaher Corporation (NYSE:DHR) entered into definitive agreement to acquire Abcam plc (NasdaqGS:ABCM) for $5.7 billion.

Levi & Korsinsky Notifies Danaher Corporation Investors of A Class Action Lawsuit and Upcoming Deadline

New minor risk - Insider selling

Lead Independent Director recently sold US$1.9m worth of stock